Sun Pharma Wins Big as Bombay HC Grants Relief in RACIRAFT Trademark Dispute with Meghmani
In a significant ruling that could reshape how pharmaceutical companies protect their brand names, Bombay High Court has stepped in to support Sun Pharmaceutical Industries Ltd. in a high stakes trademark dispute, case revolves around two similar sounding drug brands: RACIRAFT (owned by Sun Pharma) and ESIRAFT (used by Ahmedabad based Meghmani Lifesciences Ltd.).
